Methotrexate
What is methotrexate?
Methotrexate can be taken either as tablets or as an injection. If you have been prescribed injectable methotrexate (e.g. Trexject). Methotrexate is a well-established, effective treatment for several different types of inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, SLE (Systemic Lupus Erythematosus) and severe psoriasis. It may also be used for other conditions.
It can reduce damage to joints, skin and other tissues and improve symptoms such as joint pain, swelling and stiffness so it belongs to the group of medicines called disease modifying antirheumatic drugs (DMARDs). It is not a painkiller.
What benefit can you expect from your treatment?
Methotrexate may take up to 4 to 12 weeks to work. Many of the conditions that are treated with methotrexate are long-term and may need to be taken ongoing for a long time. Sometimes other DMARDs are taken with methotrexate for added benefit.
Methotrexate has been shown to prolong life and can reduce the risk of heart disease in rheumatoid arthritis.
How is methotrexate taken?
Methotrexate may be swallowed as a tablet or given by injection either into the muscle or under the skin (subcutaneously). For more information on the injections see Injectable methotrexate.
Methotrexate is taken ONCE A WEEK, on the same day each week. It is a good idea to pick a regular day of the week to take your methotrexate.
Methotrexate is best taken on an empty stomach. However, taking it with food can help to reduce nausea.
What is the dosage?
Tablets come in 2.5mg or 10mg strengths. If you have two strengths, ensure you CHECK THE STRENGTH each time you take it. Treatment may start low at 5mg or 10mg a week, increasing to an average dose of 20mg a week, and sometimes 30mg/week.
The dose is usually taken all at once on a single day. It may be divided into separate doses taken during that day if necessary.
If you stop methotrexate treatment for more than a few weeks there is a risk that your condition may worsen. Continue with your treatment unless advised by your doctor or unless side effects develop.
If you have an illness that makes you unwell enough to change plans for the day (e.g. infection or fever), it is reasonable to miss the weekly dose until you have recovered. If you are unsure, contact your doctor for advice.
Can other medicines be taken with methotrexate?
In order to reduce side effects, it is recommended that you also take folic acid or folinic acid. Your doctor will explain how much of the folic/folinic acid to take and when to take it.
Methotrexate is often taken in combination with other arthritis medicines, including:
• other DMARDs
• biological DMARDs (these act on natural substances in the body that contribute to inflammation and joint damage)
• steroid medicines such as prednisolone or cortisone injections into the joint
• anti-inflammatory medicines (NSAIDs) such as naproxen (Naprosyn) or ibuprofen (Brufen/Nurofen)
• pain medicines such as paracetamol.
Are there any side effects?
Some people experience side effects so tell your doctor if you are concerned about possible side effects.
A reduction in dose may minimise these so you may be able to continue it. Your doctor will advise on any dose changes that are necessary.
Most common possible side effects: (Folic or Folinic acid helps to reduce side-effects)
- • Fatigue, mental clouding, nausea, vomiting or diarrhoea. These can be reduced if methotrexate is taken with food or in the evening. Anti-nausea tablets can be used if needed.
• Mouth ulcers
Less common or rare possible side effects:
There are some rare but potentially serious side effects with methotrexate.
- Skin dryness, skin rashes and increased sensitivity to the sun may also occur. You should wear sunscreen and a hat when out in the sun.
- Some people also experience a temporary increase in muscle and joint pain after taking the weekly dose.
- Blood counts: Methotrexate may cause a drop in the number of white blood cells, which are needed to fight infection. It can also cause a drop in the number of platelets which help to stop bleeding.
- Regular blood tests aim to pick these problems up early if they occur.
- If you develop a sore mouth, mouth ulcers, easy bruising, nosebleeds, bleeding gums, breathlessness, infection or fever tell your doctor straight away.
- Hair thinning: This may occur rarely. It is not permanent and hair will grow back when the medicine is stopped.
- Liver: Methotrexate can inflame the liver. Regular blood tests aim to pick this up early if it occurs.
- Lungs: Methotrexate can rarely cause some inflammation in the lungs soon after starting therapy. If you have a sudden onset of breathing difficulties and/or dry cough seek medical attention as soon as possible.
- Nodule formations: Some people with rheumatoid arthritis develop nodules on their elbows or other pressure points. In some cases, methotrexate may increase this.
Long term side effects:
Methotrexate may be taken for long periods (more than 25 years). The following are rare but possible long-term issues:
- Liver:very rare cases of increased fibrous tissue in the liver have been reported after long-term treatment. This risk is increased when combined with alcohol. Regular monitoring can minimise the risk of this occurring.
- Cancer: People who have rheumatoid arthritis and other similar inflammatory conditions have a higher risk of lymphoma (a type of lymph node cancer). It is not clear if methotrexate increases this risk, but if it does, the added risk is likely very small. Methotrexate may also lower the risk of these cancers by controlling inflammation. For general cancer prevention, it is recommended to stop smoking. An annual skin check to detect any early skin cancer is also recommended.
- Fertility:Methotrexate does not affect a person’s ability to have children in the long term. See also Precautions.
More information about possible side effects:
Information that comes with your methotrexate medicine describes in detail potential serious side effects that may occur with methotrexate. Many of those side effects relate to high dose methotrexate used for the treatment of cancer. These may not be applicable to the much lower doses that are prescribed for the treatment of rheumatic conditions.
What precautions are necessary?
Blood tests:
- As methotrexate may affect the liver and blood cells, you MUST have regular blood tests during your treatment. This is very important, as you may not get symptoms with some of these problems.
- Full blood count and liver function tests will be individualised by your doctor according to your risk.
Risk of infections:
Because your immune system may be depressed, there is an increased risk of developing some infections, especially Herpes zoster (chicken pox and shingles).
You should try to avoid contact with people who have these infections. If you have an infection or persistent fever, tell your doctor straight away.
Use with other medicines:
Methotrexate can interact with other medicines. You should tell your doctor (including your GP, rheumatologist and others) about all medicines you are taking or plan to take. This includes over the counter, herbal or naturopathic medicines. You should also mention your treatment when you see other health professionals.
- Methotrexate can be taken safely with anti- inflammatory drugs (NSAIDs), as long as your kidney function is normal.
- Antibiotics containing trimethoprim (e.g. Resprim, Resprim Forte, Septrin, Alprim or Triprim) can cause problems when taken with methotrexate. If you are prescribed any of these medications you must tell the doctor you are taking methotrexate.
- Antibiotics containing trimethoprim (e.g. Resprim, Resprim Forte, Septrin, Alprim or Triprim) can cause problems when taken with methotrexate. If you are prescribed any of these medicines, you must tell the doctor you are taking methotrexate.
Vaccines
- Most vaccines can be given safely. Current recommendations are that low dose methotrexate is not a contraindication to live vaccines, such as Zostavax, MMR (measles, mumps and rubella), oral polio or yellow fever but such live vaccines should be avoided at higher doses of methotrexate.
- Pneumococcal vaccines and the yearly seasonal flu vaccinations are safe and encouraged.
- For more information on vaccination including the COVID-19 vaccination go to the ARA website
Use with alcohol:
- Alcohol increases the risk of liver damage while taking methotrexate. Methotrexate usage in heavy drinkers has been linked with cirrhosis of the liver.
- It is not known exactly how much alcohol is safe when on methotrexate, but most agree that 1 to 2 standard drinks taken once or twice a week is unlikely to cause a problem.
- Drinking more than 4 standard drinks at once, even if rarely, is strongly discouraged.
Surgery:
- If low-dose once-weekly methotrexate is continued during surgery, there seems to be no change in wound healing or increased infection.
Use in pregnancy and breastfeeding:
- Methotrexate should not be taken during pregnancy as it can cause miscarriage or foetal deformity. It should also not be taken when breastfeeding.
- You must avoid becoming pregnant during treatment and for at least three months after the end of treatment for women. A reliable method of contraception (birth control pills and/or condom) should be used during this period. If pregnancy occurs while on treatment with methotrexate you should notify your doctor immediately
- The risk of fathering a child while taking methotrexate is not entirely clear.
- More detailed information is available here.
How to store methotrexate
- Store methotrexate in a cool, dry place, away from direct heat and light (e.g. not in the bathroom).
- Keep out of reach of children.
Important things to remember
- While taking methotrexate you should see your rheumatologist regularly to make sure the treatment is working and to minimise possible side effects.
- You should have regular blood tests as directed by your rheumatologist.
- If you are concerned about any side effects, you should contact your rheumatologist as soon as possible.
For more information see the Methotrexate – printable information sheet.
This Information Sheet has been prepared using materials obtained from various sources which have been reviewed by the Australian Rheumatology Association (ARA). It contains general information only and does not contain a complete or definitive statement of all possible uses, actions, precautions, side effects or interactions of the medicines referenced. This information is not intended as medical advice for individual conditions nor for making an individual assessment of the risks and benefits of taking a particular medicine. Decisions regarding the assessment and treatment of patients are the sole responsibility of the treating medical professional, exercising their own clinical judgment and taking into account all of the circumstances and the medical history of the individual patient.
ARA has used all reasonable endeavours to ensure the information on which this Information Sheet is based is accurate and up to date. However, the ARA accepts no responsibility or liability for the accuracy, currency, reliability and/or completeness of the information contained in this Information Sheet. To the maximum extent permitted by law, the ARA expressly disclaims any liability for any injury, loss, harm or damage arising from or in connection with use of and reliance on the information contained in this Information Sheet.
This information sheet is copyright and may be reproduced in its entirety but may not be altered without prior written permission from the ARA.
Please consider the environment before printing this resource.Page updated October 2024
Discover more...
-
Advocacy & policy
Arthritis Australia advocates to government, business, industry and community leaders to improve care, management, support and quality of life for people with arthritis..
-
Programs & Research
Arthritis Australia funds research and advocates to improve care, management, support and quality-of-life for people with arthritis.
-
10 steps for living well with arthritis
Here is our 10 steps checklist to help you live with arthritis.
Sign up to Arthritis Insights
Regular updates, news and research findings delivered to your inbox: